Latest Coronavirus news
New COVID Variant, NB.1.8.1, May Now Make Up 1 in 3 U.S. Cases
posted June 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Moderna”s New Lower-Dose COVID-19 Vaccine Approved by FDA
posted June 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity 
0.1 to 0.5 Percent of SARS-CoV-2 Infections Become Persistent Monthly Specialist Briefings
Stay Connected
